-
the capacity to independently plan and execute research with precision. A keen interest in nanobodies, drug delivery, and/or brain barriers is essential, accompanied by hands-on experience in molecular biology
-
, or National funding organizations). Starting Date: as soon as possible How to apply? Please complete the online application procedure and include a detailed CV, including a list of publications, a
-
An environment that promotes personal development. In particular, a dedicated training program to broaden your expertise and enhance your skill set Scientific guidance at an internationally
-
, industrial and medical applications and new innovative biotech companies. The Laboratory for Genome Editing and System Genetics at CfM combines development of high-throughput genome editing tools with large
-
is situated at the forefront of industrial biotechnology, metabolic engineering and synthetic biology. They focus on the development of standardized, automatable, and generic tools and technologies and
-
scientist to study the human-specific genetic mechanisms of development and function of cortical neurons. Join us to undertake a highly interdisciplinary project focusing on a long-standing and fascinating
-
of researchers. Ghent, the second largest city of Flanders, is a university city and cultural hub. Only half an hour away from Antwerp and Brussels by train, and centrally located in Europe, Ghent has a scenic yet
-
of researchers. Ghent, the second largest city of Flanders, is a university city and cultural hub. Only half an hour away from Antwerp and Brussels by train, and centrally located in Europe, Ghent has a scenic yet
-
researcher to study the complexity and heterogeneity of both mouse and human microglia in neurodevelopment and neurodegeneration. By using state of the art spectral flow cytometry you will develop advanced
-
actively seeking a postdoctoral bio-informatician to advance the liquid biopsy research in the team. An important aim in TOBI is the development of novel assays for diagnosis and monitoring cancer patients